Search research articles
Contact Us
Filters
Showing results (61-70 of 133) with videos related to
Page
of 14
Sort By:
Inflammatory Bowel Diseases
|
March 18, 2009
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Javier P Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, et al.
Hepato-Gastroenterology
|
December 24, 2008
Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response
Yago Gonzalez-Lama, Ignacio Fernandez-Blanco, Antonio Lopez-SanRoman, et al.
Alimentary Pharmacology & Therapeutics
|
May 5, 2022
Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis
Carlos Taxonera, María Jesús Fernández-Aceñero, David Olivares, et al.
The American Journal of Gastroenterology
|
August 12, 2010
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines
Carlos Teruel, Antonio López-San Román, Fernando Bermejo, et al.
Digestive Diseases and Sciences
|
March 11, 2018
Self-Formation Assessed by Cumulative Summation Test Does Not Reach Recommended Thresholds for Optical Diagnosis of Colorectal Polyps ≤ 7 mm
Francisco Javier García-Alonso, Isabel Manzano Santamaría, Antonio Guardiola Arévalo, et al.
European Journal of Gastroenterology & Hepatology
|
June 21, 2012
Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience
Yago González-Lama, Carlos Taxonera, Antonio López-Sanromán, et al.
Mediators of Inflammation
|
September 5, 2015
Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
Luz María Medrano, Carlos Taxonera, Cristina González-Artacho, et al.
Journal of Crohn'S & Colitis
|
February 18, 2015
Incidence, management, and course of cancer in patients with inflammatory bowel disease
Alicia Algaba, Iván Guerra, Ignacio Marín-Jiménez, et al.
Journal of Clinical Gastroenterology
|
June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients
Javier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Journal of Clinical Gastroenterology
|
December 9, 2014
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy
Carlos Castaño-Milla, María Chaparro, Cristina Saro, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 133) with videos related to
Sort By:
Page
of 14
Inflammatory Bowel Diseases
|
March 18, 2009
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Javier P Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, et al.
Hepato-Gastroenterology
|
December 24, 2008
Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response
Yago Gonzalez-Lama, Ignacio Fernandez-Blanco, Antonio Lopez-SanRoman, et al.
Alimentary Pharmacology & Therapeutics
|
May 5, 2022
Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis
Carlos Taxonera, María Jesús Fernández-Aceñero, David Olivares, et al.
The American Journal of Gastroenterology
|
August 12, 2010
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines
Carlos Teruel, Antonio López-San Román, Fernando Bermejo, et al.
Digestive Diseases and Sciences
|
March 11, 2018
Self-Formation Assessed by Cumulative Summation Test Does Not Reach Recommended Thresholds for Optical Diagnosis of Colorectal Polyps ≤ 7 mm
Francisco Javier García-Alonso, Isabel Manzano Santamaría, Antonio Guardiola Arévalo, et al.
European Journal of Gastroenterology & Hepatology
|
June 21, 2012
Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience
Yago González-Lama, Carlos Taxonera, Antonio López-Sanromán, et al.
Mediators of Inflammation
|
September 5, 2015
Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
Luz María Medrano, Carlos Taxonera, Cristina González-Artacho, et al.
Journal of Crohn'S & Colitis
|
February 18, 2015
Incidence, management, and course of cancer in patients with inflammatory bowel disease
Alicia Algaba, Iván Guerra, Ignacio Marín-Jiménez, et al.
Journal of Clinical Gastroenterology
|
June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients
Javier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Journal of Clinical Gastroenterology
|
December 9, 2014
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy
Carlos Castaño-Milla, María Chaparro, Cristina Saro, et al.
Page
of 14